Media about us
-
Atlas to invest in extra capacity at STI test manufacturing partner Bespak
16 February 2017
Atlas Genetics has said it will expand manufacturing capacity for cartridgebased STI tests at a UK facility owned by drug delivery technology firm Bespak Europe ltd.
-
Liquid biopsies: The next frontier in cancer?
15 February 2017
As immuno-oncology dazzles and pharma companies race to develop new cancer medicines, a similar boom is underway to speed up and improve the detection of cancers.
-
Top 5 Vendors in the Pharmerging Market from 2017 to 2021: Technavio
01 February 2017
The pharmaceutical industry worldwide witnesses a dramatic regional shift to the pharmerging market, owing to the opportunities available. Considering the on-going trend of shift in global medicine dosage consumption to developing countries, about 55-60% of the global consumption should come from pharmerging markets by 2021. This will eventually lead to an incremental growth of around 25% from 2016 level.
-
Struggling Marinus gets a bump out of a positive PhII snapshot
24 January 2017
A little more than six months since its stock price was crushed by a failed late-stage program for its leading — and only — drug, tiny biotech microcap Marinus $MRNS saw its shares shoot up this morning after it offered a positive Phase II snapshot on a handful of patients who suffer from a rare genetic ailment.
-
Marinus gets a lifeline with new ganaxolone data
24 January 2017
Micro cap Marinus Pharmaceuticals was up 28% premarket this morning on positive, early data from its midstage test of ganaxolone in a rare condition that causes severe seizures.
-
JP Morgan Healthcare Conference, Day One: Genomic Health, Meridian Bioscience, Qiagen
11 January 2017
The 35th Annual JP Morgan Healthcare Conference began here Monday with several life science research tools and diagnostic firms making presentations to investors and other attendees.
-
Epic uncovers prostate cancer biomarker
09 January 2017
Biotech company Epic Sciences’ focus on circulating tumor cells (CTCs) will not only advance the clinical use of liquid biopsies and improve how metastatic cancer is treated, it says, but also identified a unique CTC biomarker in patients with metastatic prostate cancer who respond to PARP inhibitors cancer drugs in development.
-
Raindrop Vision Procedure Designed to Reduce or Eliminate Reading Glasses Now Available in Alabama.
05 January 2017
The All-New Raindrop® Near Vision Inlay is designed to improve near vision so you can once again see fine print, menus and your phone without the hassle of reading glasses.
-
Pfizer Inc. Considerable Stocks on Returns- Horizon Pharma plc
29 December 2016
Pfizer Inc. (NYSE:PFE) , stock eased up around 0.15% in early session as its gaining volume of 11.21 Million. US pharma giant, Pfizer (NYSE:PFE) and Russia’s NovaMedica, a company established in 2012 by Russian high-technology investment fund Rusnano and American healthcare fund Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio.
-
Pfizer Inc. and NovaMedica have completed the last stage of negotiations
29 December 2016
Pfizer Inc. (NYSE:PFE) and Russia’s NovaMedica, a company established in 2012 by Russian high-technology investment fund Rusnano and American healthcare fund Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio.
